B
Novo Nordisk A/S NVO
$160.76 $2.911.84%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2022 09/30/2022 06/30/2022 03/31/2022 12/31/2021
Revenue 6.61B 6.17B 5.91B 6.34B 5.89B
Total Other Revenue -- -- -- -- --
Total Revenue 6.61B 6.17B 5.91B 6.34B 5.89B
Cost of Revenue 1.13B 975.13M 868.89M 1.04B 959.51M
Gross Profit 5.47B 5.20B 5.04B 5.30B 4.93B
SG&A Expenses 2.07B 1.71B 1.69B 1.68B 1.97B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -66.48M -8.13M -21.33M -59.14M -18.45M
Total Operating Expenses 4.15B 3.44B 3.27B 3.45B 3.69B
Operating Income 2.46B 2.73B 2.63B 2.89B 2.20B
Income Before Tax 2.24B 2.44B 2.40B 2.70B 2.02B
Income Tax Expenses 374.17M 491.22M 497.80M 559.60M 341.46M
Earnings from Continuing Operations 1.87B 1.95B 1.91B 2.14B 1.67B
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 1.87B 1.95B 1.91B 2.14B 1.67B
EBIT 2.46B 2.73B 2.63B 2.89B 2.20B
EBITDA 2.64B 3.01B 2.87B 3.14B 2.24B
EPS Basic 0.83 0.86 0.84 0.94 0.73
Normalized Basic EPS 0.67 0.67 0.66 0.74 0.57
EPS Diluted 0.83 0.86 0.84 0.94 0.73
Normalized Diluted EPS 0.67 0.67 0.66 0.74 0.57
Average Basic Shares Outstanding 2.25B 2.26B 2.27B 2.28B 2.28B
Average Diluted Shares Outstanding 2.26B 2.27B 2.28B 2.28B 2.29B
Dividend Per Share 1.12 0.00 0.61 -- 1.06
Payout Ratio 0.00% 66.73% 0.00% 110.42% 0.00%
Weiss Ratings